Dr. Michael L. Cheng

Dr. Michael L. Cheng is a medical oncologist who cares for patients with lung cancer and other tumors affecting the chest, with a particular focus on non-small cell lung cancer. He strives to provide individualized, compassionate care through precision oncology (using the genetic profile of the patient's cancer to custom-tailor treatment). Cheng leads research centered on developing innovative, next-generation treatments for lung cancer, including therapeutic clinical trials with new targeted therapies and immunotherapies. He is inspired by how research discoveries can lead to tangible benefits for patients. Cheng earned his medical degree from the David Geffen School of Medicine at UCLA. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center. Before joining the UCSF faculty, he served as an assistant professor at the Dana-Farber Cancer Institute and Harvard Medical School. Cheng is a member of the American Society of Clinical Oncology (ASCO) and International Association for the Study of Lung Cancer. He has received the Career Development Award from Conquer Cancer, the ASCO Foundation, as well as research funding from the National Institutes of Health and National Cancer Institute.

Dr. Cheng is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Gastrostomy.

Dr. Cheng is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. He is actively involved in clinical research, co-authoring 97 peer reviewed articles and participating in 5 clinical trials. Dr. Cheng is currently accepting new patients.